Hill Publishing Group | contact@hillpublisher.com

Hill Publishing Group

Location:Home / Journals / International Journal of Clinical and Experimental Medicine Research /


Experience of COPD and Asthma Patients in Abuja: Using Questionnaire and Spirometry

Date: November 6,2023 |Hits: 458 Download PDF How to cite this paper

Christabel Ihedike1,*, Jonathan Ling1, John Mooney2

1Faculty of Health Sciences & Wellbeing, University of Sunderland, Sunderland, UK.

2School of Medicine, University of Aberdeen, Aberdeen, UK.

*Corresponding author: Christabel Ihedike


Most health professionals working in the respiratory department might have heard of some of the complaints from COPD or asthma patients. Therefore, in this article, the different experiences of COPD and asthma patients were assessed. A cohort study using 402 adults with COPD and asthma patients completed a respiratory questionnaire and a lung function test was conducted monthly using spirometry and was analyzed in Abuja. In total, 402 participants were recruited, 262 with COPD, and 140 with asthma. During the thirty (30) months, participants reported quality of life impairment. Reported impairment was significantly associated with FEV1 and t, the dyspnoea scale was positively linked with FEV1 changes. Participants showed impairment in their quality of life. Most of the changes in quality of life are determined by factors other than those considered relevant for treatment and follow-up. The outcome of this study showed that participants’ symptoms affect the participants’ quality of life.


[1] GBD 2015 Chronic Respiratory Disease Collaborators. (2017). Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet. Respiratory Medicine, 5(9), 691.

[2] Gayle, A.V., Minelli, C. & Quint, J.K. (2022). Respiratory-related death in individuals with incident asthma and COPD: a competing risk analysis. BMC Pulm Med., 22, 28 (2022). https://doi.org/10.1186/s12890-022-01823-4.

[3] Zeller, T. A., Beben, K., & Walker, S. (2023). Distinguishing Asthma and COPD in Primary Care: A Case-based Approach. American Family Physician, 107(3), 247-252.

[4] Efraij A., & FitzGerald J. (2015). Current and emerging treatments for severe asthma. Journal of Thoracic Disease, 7(11): E522-E525.

[5] Adeloye, D., Song, P., Zhu, Y., Campbell, H., Sheikh, A., & Rudan, I. (2022). Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis. The Lancet Respiratory Medicine, 10(5), 447-458.

[6] World Health Organization. (2022). Chronic obstructive pulmonary disease (COPD). World Health Organization (WHO); 2020. Available from https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(COPD).

[7] Ihedike C, Mooney J, & Ling J. (2023). The Effect of PM10 and NOx on COPD and Asthma Patients in Abuja Nigeria. OAJRC Environmental Science, 4(1), 1-9.

[8] Wedzicha, J. A., & Donaldson, G. C. (2003). Exacerbations of chronic obstructive pulmonary disease. Respiratory care, 48(12), 1204-1215.

[9] Huang, H. P., Chen, K. H., Tsai, C. L., Chang, W. P., Chiu, S. Y., Lin, S. R., & Lin, Y. H. (2022). Effects of High-Frequency Chest Wall Oscillation on Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. International journal of chronic obstructive pulmonary disease, 17, 2857-2869. https://doi.org/10.2147/COPD.S378642.

[10] Basil G Bereza, Anders Troelsgaard Nielsen, Sverrir Valgardsson, Michiel EH Hemels, & Thomas R Einarson. (2015). Patient preferences in severe COPD and asthma: a comprehensive literature review. International Journal of Chronic Obstructive Pulmonary Disease, 10: 739-744, DOI: 10.2147/COPD.S82179.

[11] Viegi, G., Maio, S., Fasola, S., & Baldacci, S. (2020). Global Burden of Chronic Respiratory Diseases. Journal of aerosol medicine and pulmonary drug delivery, 33(4), 171-177. https://doi.org/10.1089/jamp.2019.1576.

[12] Hannah Collacott, Dian Zhang, Sebastian Heidenreich, Tommi Tervonen. (2022). A Systematic and Critical Review of Discrete Choice Experiments in Asthma and Chronic Obstructive Pulmonary Disease. The Patient -Patient-Centered Outcomes Research 15:1, pages 55-68.

[13] Gibson PG, Simpson JL (2009). The overlap syndrome of asthma and COPD: what are its features and how important is it? Thorax, 2009; 64:728-735.

[14] Rabe K. F. (2011). Update on roflumilast, a phosphodiesterase 4 inhibitor for the treatment of chronic obstructive pulmonary disease. British journal of pharmacology, 163(1), 53-67. https://doi.org/10.1111/j.1476-5381.2011.01218.x.

[15] Martínez-García, M.A., Perpiñá-Tordera, M., Román-Sánchez, P., & Soler-Cataluña, J.J. (2006). Inhaled steroids improve quality of life in patients with steady-state bronchiectasis. Respiratory medicine, 100(9), 1623-32.

[16] Karbasi-Afshar, R., Aslani, J., & Ghanei, M. (2014). Efficacy and safety of inhaler steroids in COPD patients: Systematic review and meta-analysis of randomized placebo-controlled trials. Caspian journal of internal medicine, 5(3), 130-136.

[17] Shah, S. S., Ohlsson, A., Halliday, H. L., & Shah, V. S. (2017). Inhaled versus systemic corticosteroids for preventing bronchopulmonary dysplasia in ventilated very low birth weight preterm neonates. The Cochrane database of systematic reviews, 10(10), CD002058. https://doi.org/10.1002/14651858.CD002058.pub3.

[18] Beeh, K. M., & Beier, J. (2010). The short, the long and the "ultra-long": why duration of bronchodilator action matters in chronic obstructive pulmonary disease. Advances in therapy, 27(3), 150-159. https://doi.org/10.1007/s12325-010-0017-6.

[19] Lewis, A., Axson, E. L., Potts, J., Tarnowska, R., Vioix, H., & Quint, J. K. (2019). Protocol for a systematic literature review and network meta-analysis of the clinical benefit of inhaled maintenance therapies in chronic obstructive pulmonary disease. BMJ open, 9(2), e025048. https://doi.org/10.1136/bmjopen-2018-025048.

[20] Kiliç, L., Tural Önür, S., Gorek Dilektasli, A., Ulubay, G., & Balcı, A. (2023). Understanding the Impact of Pulmonary Rehabilitation on Airway Resistance in Patients with Severe COPD: A Single-Center Retrospective Study. International journal of chronic obstructive pulmonary disease, 18, 1-10. https://doi.org/10.2147/COPD.S384127.

[21] Jacobs J, Lisdonk E, I Smeele, C van Weel, & RPTM Grol. (2001). Management of patients with asthma and COPD: monitoring quality of life and the relationship to subsequent GP interventions. Family Practice, Volume 18, Issue 6, December 2001, Pages 574-580, https://doi.org/10.1093/fampra/18.6.574.

[22] Singh, D., Agusti, A., Anzueto, A., Barnes, P. J., Bourbeau, J., Celli, B. R., Criner, G. J., Frith, P., Halpin, D. M. G., Han, M., López Varela, M. V., Martinez, F., Montes de Oca, M., Papi, A., Pavord, I. D., Roche, N., Sin, D. D., Stockley, R., Vestbo, J., Wedzicha, J. A., … Vogelmeier, C. (2019). Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019. The European Respiratory Journal, 53(5), 1900164.


How to cite this paper

Experience of COPD and Asthma Patients in Abuja: Using Questionnaire and Spirometry

How to cite this paper: Christabel Ihedike, Jonathan Ling, John Mooney. (2023) Experience of COPD and Asthma Patients in Abuja: Using Questionnaire and Spirometry. International Journal of Clinical and Experimental Medicine Research7(4), 524-530.

DOI: http://dx.doi.org/10.26855/ijcemr.2023.10.002

Volumes & Issues

Free HPG Newsletters

Add your e-mail address to receive free newsletters from Hill Publishing Group.

Contact us

Hill Publishing Group

8825 53rd Ave

Elmhurst, NY 11373, USA

E-mail: contact@hillpublisher.com

Copyright © 2019 Hill Publishing Group Inc. All Rights Reserved.